4/A//SEC Filing
Zosano Pharma Corp 4/A
Accession 0001587221-17-000020
CIK 0001587221operating
Filed
May 25, 8:00 PM ET
Accepted
May 26, 5:53 PM ET
Size
7.4 KB
Accession
0001587221-17-000020
Insider Transaction Report
Form 4/AAmended
WALKER JOHN PETER
Director
Transactions
- Purchase
Common Stock
2017-05-24$1.34/sh+36,166$48,553→ 169,344 total - Purchase
Common Stock
2017-05-25$1.37/sh+37,550$51,338→ 206,894 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.35, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.38, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F3]This Amended Form 4 is being filed to revise Footnotes 1 and 2 of the original Form 4 to state that the shares were "purchased" and not "sold." This amendment corrects an administrative error.
Documents
Issuer
Zosano Pharma Corp
CIK 0001587221
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001587221
Filing Metadata
- Form type
- 4/A
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 5:53 PM ET
- Size
- 7.4 KB